메뉴 건너뛰기




Volumn 30, Issue 5, 2007, Pages 1014-1017

Azathioprine and diffuse alveolar haemorrhage: The pharmacogenetics of thiopurine methyltransferase

Author keywords

Azathioprine; Diffuse alveolar haemorrhage; Myelotoxicty; Pharmacogenetics; Polymorphism; Thiopurine methyltransferase

Indexed keywords

AZATHIOPRINE; PREDNISONE; THIOPURINE METHYLTRANSFERASE;

EID: 38849141668     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00026107     Document Type: Article
Times cited : (25)

References (29)
  • 1
  • 2
    • 18144387938 scopus 로고    scopus 로고
    • Is idiopathic pulmonary fibrosis now treatable?
    • du Bois RM. Is idiopathic pulmonary fibrosis now treatable? Am J Respir Crit Care Med 2005; 171: 939-940.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 939-940
    • du Bois, R.M.1
  • 3
    • 0034133548 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS)
    • American Thoracic Society
    • American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 646-664
  • 4
    • 0026758498 scopus 로고
    • The clinical pharmacology of 6-mercaptopurine
    • Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992; 43: 329-339.
    • (1992) Eur J Clin Pharmacol , vol.43 , pp. 329-339
    • Lennard, L.1
  • 5
    • 0034034158 scopus 로고    scopus 로고
    • Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
    • McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 567-572.
    • (2000) Leukemia , vol.14 , pp. 567-572
    • McLeod, H.L.1    Krynetski, E.Y.2    Relling, M.V.3    Evans, W.E.4
  • 6
    • 0030934850 scopus 로고    scopus 로고
    • Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
    • Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608-614.
    • (1997) Ann Intern Med , vol.126 , pp. 608-614
    • Yates, C.R.1    Krynetski, E.Y.2    Loennechen, T.3
  • 7
    • 0036009619 scopus 로고    scopus 로고
    • The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics
    • McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3: 89-98.
    • (2002) Pharmacogenomics , vol.3 , pp. 89-98
    • McLeod, H.L.1    Siva, C.2
  • 8
    • 3242762099 scopus 로고    scopus 로고
    • Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
    • Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004; 14: 407-417.
    • (2004) Pharmacogenetics , vol.14 , pp. 407-417
    • Schaeffeler, E.1    Fischer, C.2    Brockmeier, D.3
  • 9
    • 0035871560 scopus 로고    scopus 로고
    • Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine and azathioprine
    • Evans WE, Hon YY, Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine and azathioprine. J Clin Oncol 2001; 19: 2293-2301.
    • (2001) J Clin Oncol , vol.19 , pp. 2293-2301
    • Evans, W.E.1    Hon, Y.Y.2    Bomgaars, L.3
  • 10
    • 0037237923 scopus 로고    scopus 로고
    • Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD
    • Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord 2003; 3: Suppl. 1, S30-S38.
    • (2003) Rev Gastroenterol Disord , vol.3 , Issue.SUPPL. 1
    • Seidman, E.G.1
  • 11
    • 38849166399 scopus 로고    scopus 로고
    • Drug metabolite monitoring of azathioprine/6-MP therapy: Contribution of thiopurine methyltransferase gene polymorphisms: 69
    • Dervieux T, Matsutani M, Barry M, Siedman E. Drug metabolite monitoring of azathioprine/6-MP therapy: contribution of thiopurine methyltransferase gene polymorphisms: 69. Ther Drug Monit 2005; 27: 228.
    • (2005) Ther Drug Monit , vol.27 , pp. 228
    • Dervieux, T.1    Matsutani, M.2    Barry, M.3    Siedman, E.4
  • 12
    • 0032212759 scopus 로고    scopus 로고
    • Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine
    • Black AJ, McLeod HL, Capell HA, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Int Med 1998; 129: 716-718.
    • (1998) Ann Int Med , vol.129 , pp. 716-718
    • Black, A.J.1    McLeod, H.L.2    Capell, H.A.3
  • 13
    • 0034093057 scopus 로고    scopus 로고
    • Genotypic analysis of the thiopurine S-methyltransferase gene in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    • Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of the thiopurine S-methyltransferase gene in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000; 118: 1025-1030.
    • (2000) Gastroenterology , vol.118 , pp. 1025-1030
    • Colombel, J.F.1    Ferrari, N.2    Debuysere, H.3
  • 14
    • 21744452321 scopus 로고    scopus 로고
    • Inosine triphosphate pyrophosphatease gene mutations predicts myelosuppresion in IBD patients treated with azathioprine
    • Zelinkova Z, Derijks LJ, Stokkers PC, et al. Inosine triphosphate pyrophosphatease gene mutations predicts myelosuppresion in IBD patients treated with azathioprine. Gastroenterology 2004; 126: Suppl. 2, A112.
    • (2004) Gastroenterology , vol.126 , Issue.SUPPL. 2
    • Zelinkova, Z.1    Derijks, L.J.2    Stokkers, P.C.3
  • 15
    • 12144285961 scopus 로고    scopus 로고
    • Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
    • Marinaki AM, Ansari A, Duley JA, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004; 14: 181-187.
    • (2004) Pharmacogenetics , vol.14 , pp. 181-187
    • Marinaki, A.M.1    Ansari, A.2    Duley, J.A.3
  • 16
    • 9944221077 scopus 로고    scopus 로고
    • The impact of thiopurine s-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation
    • Fabre MA, Jones DC, Bunce M, et al. The impact of thiopurine s-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation. Transpl Int 2004; 17: 531-539.
    • (2004) Transpl Int , vol.17 , pp. 531-539
    • Fabre, M.A.1    Jones, D.C.2    Bunce, M.3
  • 17
    • 11144340253 scopus 로고    scopus 로고
    • British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology
    • Anstey AV, Wakelin S, Reynolds NJ, British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol 2004; 151: 1123-1132.
    • (2004) Br J Dermatol , vol.151 , pp. 1123-1132
    • Anstey, A.V.1    Wakelin, S.2    Reynolds, N.J.3
  • 18
    • 0038345082 scopus 로고    scopus 로고
    • Prospects and limits of pharmacogenetics: The thiopurine methyl transferase (TPMT) experience
    • Van Aken J, Schmedders M, Feurerstein G, Kollek R. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience. Am J Pharmacogenomics 2003; 3: 149-155.
    • (2003) Am J Pharmacogenomics , vol.3 , pp. 149-155
    • Van Aken, J.1    Schmedders, M.2    Feurerstein, G.3    Kollek, R.4
  • 19
    • 0036667951 scopus 로고    scopus 로고
    • Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: Impact of thiopurine S-methyltransferase polymorphisms
    • Schwab M, Schaffeler E, Marx C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphisms. Pharmacogenetics 2002; 12: 421-423.
    • (2002) Pharmacogenetics , vol.12 , pp. 421-423
    • Schwab, M.1    Schaffeler, E.2    Marx, C.3
  • 20
    • 0036894866 scopus 로고    scopus 로고
    • Practical Pharmacogenetics: The cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine
    • Marra CA, Esdaile JM, Anis AH. Practical Pharmacogenetics: The cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol 2002; 29: 2507-2512.
    • (2002) J Rheumatol , vol.29 , pp. 2507-2512
    • Marra, C.A.1    Esdaile, J.M.2    Anis, A.H.3
  • 21
    • 4644241129 scopus 로고    scopus 로고
    • Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease
    • Winter J, Walker A, Shapiro D, Gaffney D, Spooner RJ, Mills PR. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20: 593-599.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 593-599
    • Winter, J.1    Walker, A.2    Shapiro, D.3    Gaffney, D.4    Spooner, R.J.5    Mills, P.R.6
  • 22
    • 33747167334 scopus 로고    scopus 로고
    • Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease
    • Priest VL, Begg EJ, Gardiner SJ, et al. Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease. Pharmacoeconomics 2006; 24: 767-781.
    • (2006) Pharmacoeconomics , vol.24 , pp. 767-781
    • Priest, V.L.1    Begg, E.J.2    Gardiner, S.J.3
  • 23
    • 33747168764 scopus 로고    scopus 로고
    • Cost-effectiveness of pharmacogenomics in clinical practice: A case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe
    • van den Akker-van Marle ME, Gurwitz D, Detmar SB, et al. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics 2006; 7: 783-792.
    • (2006) Pharmacogenomics , vol.7 , pp. 783-792
    • van den Akker-van Marle, M.E.1    Gurwitz, D.2    Detmar, S.B.3
  • 24
    • 0033941305 scopus 로고    scopus 로고
    • Screening for azathioprine toxicity: A pharmacoeconomic analysis based on a target case
    • Tavadia SM, Mydlarski PR, Reis MD, et al. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 2000; 42: 628-632.
    • (2000) J Am Acad Dermatol , vol.42 , pp. 628-632
    • Tavadia, S.M.1    Mydlarski, P.R.2    Reis, M.D.3
  • 25
    • 33745460088 scopus 로고    scopus 로고
    • Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study
    • Gisbert JP, Luna M, Mate J, Gonzalez-Guijarro L, Cara C, Pajares JM. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Hepatogastroenterology 2006; 53: 399-404.
    • (2006) Hepatogastroenterology , vol.53 , pp. 399-404
    • Gisbert, J.P.1    Luna, M.2    Mate, J.3    Gonzalez-Guijarro, L.4    Cara, C.5    Pajares, J.M.6
  • 26
    • 17644381606 scopus 로고    scopus 로고
    • Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: Effect on cost and adverse events
    • Sayani FA, Prosser C, Bailey RJ, Jacobs P, Fedorak RN. Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events. Can J Gastroenterol 2005; 19: 147-151.
    • (2005) Can J Gastroenterol , vol.19 , pp. 147-151
    • Sayani, F.A.1    Prosser, C.2    Bailey, R.J.3    Jacobs, P.4    Fedorak, R.N.5
  • 27
    • 4344602852 scopus 로고    scopus 로고
    • Guidelines for the management of inflammatory bowel disease in adults
    • Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53: V1-V16.
    • (2004) Gut , vol.53
    • Carter, M.J.1    Lobo, A.J.2    Travis, S.P.L.3
  • 28
    • 3843109109 scopus 로고    scopus 로고
    • Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
    • Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1371-1385
    • Kornbluth, A.1    Sachar, D.B.2
  • 29
    • 4844231301 scopus 로고    scopus 로고
    • Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis
    • Luppi F, Cerri S, Beghe B, Fabbri LM, Richeldi L. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis. Respir Med 2004; 98: 1035-1044.
    • (2004) Respir Med , vol.98 , pp. 1035-1044
    • Luppi, F.1    Cerri, S.2    Beghe, B.3    Fabbri, L.M.4    Richeldi, L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.